Xtant Medical Holdings (XTNT) Liabilities and Shareholders Equity (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $94.1 million in Q4 2025.

• Quarterly Liabilities and Shareholders Equity changed 0.33% year-over-year to $94.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $399.8 million (up 4.59% YoY) and the FY2025 annual result came in at $94.1 million, changed 0.33% from the prior year.
• Liabilities and Shareholders Equity slipped to $94.1 million in Q4 2025 per XTNT's latest filing, from $106.3 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $106.3 million in Q3 2025 and bottomed at $52.7 million in Q2 2022.
• The 5-year median for Liabilities and Shareholders Equity is $78.6 million (2023), against an average of $77.3 million.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity dropped 11.67%; it then soared 64.15% in 2023.
• Tracing XTNT's Liabilities and Shareholders Equity over 5 years: stood at $54.7 million in 2021, then climbed by 10.12% to $60.2 million in 2022, then surged by 53.77% to $92.6 million in 2023, then climbed by 1.32% to $93.8 million in 2024, then rose by 0.33% to $94.1 million in 2025.
• Per Business Quant, the three latest XTNT Liabilities and Shareholders Equity figures stand at $94.1 million (Q4 2025), $106.3 million (Q3 2025), and $103.5 million (Q2 2025).

Peer Comparison